Your browser doesn't support javascript.
loading
ENIGMA-DTI: Translating reproducible white matter deficits into personalized vulnerability metrics in cross-diagnostic psychiatric research.
Kochunov, Peter; Hong, L Elliot; Dennis, Emily L; Morey, Rajendra A; Tate, David F; Wilde, Elisabeth A; Logue, Mark; Kelly, Sinead; Donohoe, Gary; Favre, Pauline; Houenou, Josselin; Ching, Christopher R K; Holleran, Laurena; Andreassen, Ole A; van Velzen, Laura S; Schmaal, Lianne; Villalón-Reina, Julio E; Bearden, Carrie E; Piras, Fabrizio; Spalletta, Gianfranco; van den Heuvel, Odile A; Veltman, Dick J; Stein, Dan J; Ryan, Meghann C; Tan, Yunlong; van Erp, Theo G M; Turner, Jessica A; Haddad, Liz; Nir, Talia M; Glahn, David C; Thompson, Paul M; Jahanshad, Neda.
Afiliação
  • Kochunov P; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Hong LE; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Dennis EL; Psychiatry Neuroimaging Laboratory, Brigham & Women's Hospital, Boston, Massachusetts, USA.
  • Morey RA; Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
  • Tate DF; Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Wilde EA; George E. Wahlen VA, Salt Lake City, Utah, USA.
  • Logue M; Brain Imaging and Analysis Center, Duke University, Durham, North Carolina, USA.
  • Kelly S; Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Donohoe G; George E. Wahlen VA, Salt Lake City, Utah, USA.
  • Favre P; Department of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Houenou J; George E. Wahlen VA, Salt Lake City, Utah, USA.
  • Ching CRK; VA Boston Healthcare System, National Center for PTSD, Boston, Massachusetts, USA.
  • Holleran L; Boston University School of Medicine, Department of Psychiatry, Boston, Massachusetts, USA.
  • Andreassen OA; Boston University School of Medicine, Biomedical Genetics, Boston, Massachusetts, USA.
  • van Velzen LS; Boston University School of Public Health, Department of Biostatistics, Boston, Massachusetts, USA.
  • Schmaal L; Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
  • Villalón-Reina JE; Harvard Medical School, Boston, Massachusetts, USA.
  • Bearden CE; Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland.
  • Piras F; Neurospin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.
  • Spalletta G; INSERM Unit U955, team "Translational Neuro-Psychiatry", Créteil, France.
  • van den Heuvel OA; Neurospin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.
  • Veltman DJ; INSERM Unit U955, team "Translational Neuro-Psychiatry", Créteil, France.
  • Stein DJ; Psychiatry Department, Assistance Publique-Hôpitaux de Paris (AP-HP), CHU Mondor, Créteil, France.
  • Ryan MC; Faculté de Médecine, Université Paris Est Créteil, Créteil, France.
  • Tan Y; Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
  • van Erp TGM; Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland.
  • Turner JA; Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Haddad L; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Nir TM; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
  • Glahn DC; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
  • Thompson PM; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
  • Jahanshad N; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
Hum Brain Mapp ; 43(1): 194-206, 2022 01.
Article em En | MEDLINE | ID: mdl-32301246
ABSTRACT
The ENIGMA-DTI (diffusion tensor imaging) workgroup supports analyses that examine the effects of psychiatric, neurological, and developmental disorders on the white matter pathways of the human brain, as well as the effects of normal variation and its genetic associations. The seven ENIGMA disorder-oriented working groups used the ENIGMA-DTI workflow to derive patterns of deficits using coherent and coordinated analyses that model the disease effects across cohorts worldwide. This yielded the largest studies detailing patterns of white matter deficits in schizophrenia spectrum disorder (SSD), bipolar disorder (BD), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), traumatic brain injury (TBI), and 22q11 deletion syndrome. These deficit patterns are informative of the underlying neurobiology and reproducible in independent cohorts. We reviewed these findings, demonstrated their reproducibility in independent cohorts, and compared the deficit patterns across illnesses. We discussed translating ENIGMA-defined deficit patterns on the level of individual subjects using a metric called the regional vulnerability index (RVI), a correlation of an individual's brain metrics with the expected pattern for a disorder. We discussed the similarity in white matter deficit patterns among SSD, BD, MDD, and OCD and provided a rationale for using this index in cross-diagnostic neuropsychiatric research. We also discussed the difference in deficit patterns between idiopathic schizophrenia and 22q11 deletion syndrome, which is used as a developmental and genetic model of schizophrenia. Together, these findings highlight the importance of collaborative large-scale research to provide robust and reproducible effects that offer insights into individual vulnerability and cross-diagnosis features.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imagem de Tensor de Difusão / Substância Branca / Transtornos Mentais Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imagem de Tensor de Difusão / Substância Branca / Transtornos Mentais Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos